MARKET

JAZZ

JAZZ

Jazz Pharmaceuticals Plc
NASDAQ
110.04
-10.78
-8.92%
Pre Market: 106.50 -3.54 -3.22% 06:29 04/07 EDT
OPEN
116.48
PREV CLOSE
120.82
HIGH
117.12
LOW
109.76
VOLUME
399
TURNOVER
0
52 WEEK HIGH
148.06
52 WEEK LOW
99.06
MARKET CAP
6.68B
P/E (TTM)
12.72
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at JAZZ last week (0331-0404)?
Weekly Report · 1h ago
European pharma evaluates ways to mitigate impact of tariff uncertainty
Seeking Alpha · 2d ago
AMGN's Uplizna Gets FDA Nod for 2nd Rare Autoimmune Disease Indication
NASDAQ · 2d ago
SNY's Rilzabrutinib Gets FDA's Orphan Drug Tag for Two Rare Diseases
NASDAQ · 3d ago
AXSM Stock Down on Top-Line Data From Depression Study on Solriamfetol
Barchart · 4d ago
Alkermes Begins Idiopathic Hypersomnia Study on ALKS 2680
Barchart · 5d ago
VRTX Provides Mixed Updates for Type 1 Diabetes Pipeline Candidates
NASDAQ · 5d ago
Jazz Pharmaceuticals: Undervalued Stock with Strong Growth Potential Despite Tariff Concerns
TipRanks · 5d ago
More
About JAZZ
More
Jazz Pharmaceuticals PLC is a biotechnology company. The Company is engaged in developing medicines for people with serious diseases. The Company’s lead marketed products include Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution, Xyrem (sodium oxybate) oral solution, Epidiolex (cannabidiol) oral solution, Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn), Zepzelca (lurbinectedin), Defitelio (defibrotide sodium) AND Vyxeos (daunorubicin and cytarabine) liposome for injection. The Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution product is for the treatment of cataplexy or excessive daytime sleepiness (EDS), in patients with narcolepsy seven years of age and older. The Xyrem (sodium oxybate) oral solution product is for the treatment of cataplexy or EDS in patients with narcolepsy seven years of age and older. The Defitelio (defibrotide sodium) product is for the treatment of hepatic veno-occlusive disease (VOD).
Recently
Symbol
Price
%Change

Webull offers Jazz Pharmaceuticals PLC stock information, including NASDAQ: JAZZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JAZZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JAZZ stock methods without spending real money on the virtual paper trading platform.